Jump to navigation
The summer has been a rough time for Canadian cannabis stocks and Horizons Marijuana Life Sciences ETF (HMMJ.TO) (HMLSF) has fallen approx. 25% from its late June highs.
This weakness has taken place on light volume and we have been closely monitoring this trend. Although the decline has been painful, it does not come as a surprise. During the last three years, we have seen the cannabis sector pullback during the summer months and this year has been no different.
The Hydropothecary Corporation (“HEXO” or the “Company”) (TSX:HEXO) has reached a major milestone in its expansion plans, designed to position HEXO as one of the largest cannabis producers in Canada.
Aurora Cannabis Inc. ("Aurora") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and CannaRoyalty Corp.
Canopy Growth Corporation ("Canopy Growth") (TSX:WEED) (NYSE:CGC) and Hiku Brands Company Ltd. ("Hiku") (CSE:HIKU) (together, the "Companies") are pleased to announce that they have entered into a definitive arrangement agreement (the "Agreement") pursuant to which Canopy Growth will acquire all of the issued and outstanding common shares of Hiku (the "Transaction").
LiveWell Foods is going public this week and cannabis investors need to be aware of this opportunity. Over the last year, the company has been nothing short of an execution story and has significantly advanced its story during this time.
MedReleaf Corp. (TSX:LEAF) ("MedReleaf" or the "Company") and BioPharma Services Inc. (BioPharma) today announced they have entered into an exclusive agreement to conduct clinical research for cannabis and cannabis derived products. Under the agreement BioPharma will become an extension of MedReleaf's clinic development team.
Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced that the Company, through its wholly owned subsidiary Pedanios GmbH ("Pedanios"), has signed a collaboration agreement with Heinrich Klenk GmbH & Co. KG ("Klenk"), one of Europe's largest medicinal plant companies.
Aurora Cannabis Inc. ("Aurora") (TSX: ACB) and MedReleaf Corp.
Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQB: OGRMF) (the "Company" or "Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, is pleased to announce it has entered a non-binding term sheet to acquire up to 25 per cent of alpha-cannabis Pharma GmbH ("Alpha-Cannabis Germany" or "ACG") located in Stadthagen, Germany.
Processing, please wait. This may take up to 15 seconds to complete.
Please do not close your browser.